CTRI/2018/03/012266
Recruiting
N/A
Genzyme Rare disease registries (MPS I Disease Registry Protocol).
Sanofi Synthelabo India Private Limited0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- MPS I DiseaseHealth Condition 2: E760- Mucopolysaccharidosis, type I
- Sponsor
- Sanofi Synthelabo India Private Limited
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. All age group from new born to old age allowed
- •2\. All patients with a confirmed diagnosis of MPS I disease who are willing and able to provide written informed consent and any additional authorization documents required by local law to send health information to the Registry are eligible for inclusion, regardless of whether they are receiving disease therapy including ERT (such as laronidase) and irrespective of the commercial product with which they are being treated.
- •3\. A confirmed diagnosis of MPS I consists of documented biochemical evidence of a deficiency in α\-Liduronidase enzyme activity or mutation(s) in the gene coding for α\-L\-iduronidase
Exclusion Criteria
- •No Exclusion Criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Pompe Disease Registry.An observational program for patients with Pompe disease that was designed to track the natural history and outcomes of patients.Health Condition 1: E740- Glycogen storage diseaseHealth Condition 2: null- Pompe DiseaseCTRI/2018/03/012267Sanofi Synthelabo India Private Limited
Recruiting
N/A
Disease Registry for patients with Fabry disease.An observational program for patients with Fabry disease that was designed to track the natural history and outcomes of patients.Health Condition 1: null- Fabry DiseaseHealth Condition 2: E752- Other sphingolipidosisCTRI/2018/03/012268Sanofi Synthelabo India Private Limited
Recruiting
N/A
Disease registry for patients with Gaucher disease.An observational program for patients with Gaucher disease that was designed to track the natural history and outcomes of patients.Health Condition 1: null- Gaucher DiseaseHealth Condition 2: E752- Other sphingolipidosisCTRI/2018/03/012357Sanofi Synthelabo India Private Limited
Completed
N/A
Central Information Portal for rare diseases - Sub-project 2: Information Request from patients and their families.Rare diseases.DRKS00006011niversität Hannover - Center for Health Economics Research92
Not Yet Recruiting
N/A
development patient data set by recording and maintenance a registry at the national levelCTRI/2019/06/019661Indian Council of Medical Research